Search clinical trial failures

Find the biological reasons clinical trials stop early

Clinical Trial Failures is a searchable database of terminated, suspended, and withdrawn clinical trials. It is built to surface the strongest biological failure signals in registry text, especially weak efficacy, futility, safety issues, and other signs that an intervention did not work as intended.

Instead of reading thousands of trial records manually, you can review clinical trial failures by phase, sponsor, disease area, condition, intervention, geography, and stop reason.

What this web app actually helps you answer

The app is designed for biotech and pharma teams, investors, consultants, and researchers who want a faster way to study why clinical trials fail. The strongest use case is identifying whether a stopped study reflects a likely biological failure versus an operational, strategic, or funding decision.

  • Find failed clinical trials linked to efficacy or futility concerns.
  • Separate safety-led stops from operational or sponsor-led stops.
  • Trace sponsor patterns across repeated terminated, suspended, and withdrawn trials.
  • Move from broad dataset views into trial-level stop language quickly.

Searchable records

Browse terminated, suspended, and withdrawn clinical trial records in one place.

Reason-based filtering

Focus on likely efficacy, safety, operational, and other failure patterns.

Biological vs non-biological stops

Use the failure framing to distinguish scientific signals from administrative noise.

Frequently asked questions

These are the main questions people ask when they are researching clinical trial failures and the biological reasons trials stop.

What counts as a clinical trial failure?

This site focuses on trials that were terminated, suspended, or withdrawn. Not every stopped study failed scientifically, but these records often contain the clearest signals behind clinical trial failures.

Why do clinical trials fail?

Clinical trials can stop because of weak efficacy, futility, safety issues, operational problems, funding constraints, sponsor strategy changes, or regulatory factors. The app is most useful when you want to isolate probable biological failure from those other causes.

Who is this useful for?

It is built for teams and researchers who want faster access to structured failed clinical trial intelligence, including operators, analysts, consultants, and investors.